Scientists may have found a way to prevent statin muscle pain
Researchers at McMaster University have identified a biological pathway that links statin use to muscle pain and weakness. By blocking this specific immune response in muscle cells, scientists hope to develop treatments that allow patients to continue cholesterol-lowering therapy without side effects.
Why it matters
Improving statin tolerance could significantly increase patient adherence to life-saving cardiovascular treatments, potentially reducing heart attacks and strokes.
Millions of people take statins to lower cholesterol and reduce their chances of having a heart attack or stroke. For some patients, however, the medications can cause muscle pain, weakness, and difficulty exercising, making it harder to stay on treatment.
Researchers at McMaster University have now identified a biological pathway that could help explain why these muscle symptoms develop. The finding may eventually lead to treatments that make statins easier to tolerate without reducing their important cardiovascular benefits.
Published in Science Advances, the study points to a previously unrecognized interaction between the immune system and muscle cell metabolism. The mechanism appears to contribute to muscle damage caused by statins and challenges earlier ideas about the origins of these side effects.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in